SCHEMBL664074

SCHEMBL664074

CC(C)C[C@@H](CC(N)=O)CC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 2/20 0.67
CACNB3 P54284 1/20 0.67
CACNA1C Q13936 1/20 0.67
PGR P06401 1/20 0.67
ADRA1A P35348 1/20 0.67
HTR2B P41595 1/20 0.67
CACNA2D2 Q9NY47 1/20 0.67
SLC7A5 Q01650 1/20 0.41
ECE1 P42892 1/20 0.37
RNPEP Q9H4A4 1/20 0.37
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
MME P08473 2/20 0.36
GABRR1 P24046 2/20 0.33
LAP3 P28838 2/20 0.33
SLC22A6 Q4U2R8 1/20 0.33
LMNA P02545 1/20 0.33
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL664033 1.00 CACNA2D1 (0.67) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL664076 1.00 CACNA2D1 (0.67) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL8829767 1.00 CACNA2D1 (0.67) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL9105209 0.91 CACNA2D1 (0.52) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL1410027 0.89 CACNA2D1 (0.74) CACNA2D1CACNB3CACNA1CPGRADRA1A
Benzene SCHEMBL27913108 0.88 CACNA2D1 (0.58) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL4659755 0.86 CACNA2D1 (0.52) CACNA2D1CACNB3CACNA1CPGRADRA1A
Ethyl Acetate SCHEMBL28029630 0.85 CACNA2D1 (0.50) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL4412290 0.84 CACNA2D1 (0.74) CACNA2D1CACNB3CACNA1CPGRADRA1A
SCHEMBL12575347 0.83 CACNA2D1 (0.62) CACNA2D1CACNB3CACNA1CPGRADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107428761-A Prepare dipeptidyl peptidase 4(DPP‑4)The method of inhibitor 李氏制药有限公司 2017-12-01 CN claimed
EP-3242879-A1 NOVEL PROCESS FOR THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR Lee Pharma Ltd. (IN) 2017-11-15 EP claimed
WO-2016110750-A1 NOVEL PROCESS FOR THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR LEE PHARMA LIMITED (IN) 2016-07-14 WO claimed
CN-105481712-A Racemization recycling method of Pregabalin intermediate mother liquor from resolution CHANGZHOU SUNLIGHT PHARM CO LTD 2016-04-13 CN claimed
EP-2035368-B1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES LABORATORIO CHIMICO INT SPA (IT) 2015-05-27 EP claimed
US-20140323758-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE LUPIN LIMITED (IN) 2014-10-30 US claimed
EP-2782901-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE Lupin Limited (IN) 2014-10-01 EP claimed
WO-2013076630-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE LUPIN LIMITED (IN) 2013-05-30 WO claimed
CN-102126979-A Preparation method of optically pure 3-(carbamoylmethyl)-5-methyl-hexanoic acid CHENGDU ORGANIC CHEMICALS CO 2011-07-20 CN claimed
WO-2011077463-A1 PROCESS FOR PREPARING PREGABALIN AND ITS INTERMEDIATE MSN LABORATORIES LIMITED (IN) 2011-06-30 WO claimed
CN-101857552-A Resolution method of 3-(carbamoylmethyl)-5-methylhexanol CHENGDU ORGANIC CHEMICALS CO 2010-10-13 CN claimed
US-20090192331-A1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 2009-07-30 US claimed
EP-2035368-A1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES Laboratorio Chimico Internazionale S.p.A. (IT) 2009-03-18 EP claimed
WO-2008004044-A1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 2008-01-10 WO claimed
EP-0828704-B1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER LAMBERT CO (US) 2002-03-13 EP claimed
EP-0828704-A1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER-LAMBERT COMPANY (US) 1998-03-18 EP claimed
US-5629447-A Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-05-13 US claimed
US-5616793-A Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-04-01 US claimed
WO-1996038405-A1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER-LAMBERT COMPANY (US) 1996-12-05 WO claimed
CN-116515800-B PaDP protein and application of mutant thereof in enzymatic synthesis of pregabalin chiral intermediate 中国科学院微生物研究所 2025-06-17 CN disclosed
CN-119955872-A Synthetic protein of R- (-) -3- (carbamoylmethyl) -5-methylhexanoic acid, mutant and application thereof 中国科学院微生物研究所 2025-05-09 CN disclosed
US-20250043323-A1 BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF PREGABALIN INTERMEDIATES Enzymaster (Ningbo) Bio-Engineering Co., Ltd (CN) 2025-02-06 US disclosed
CN-114164198-B (R) - (-) -3- (carbamoylmethyl) -5-methylhexanoic acid synthetic protein, mutant and application thereof 中国科学院微生物研究所 2025-01-07 CN disclosed
EP-4433602-A1 BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF PREGABALIN INTERMEDIATES Enzymaster (Ningbo) Bio-Engineering Co., Ltd. (CN) 2024-09-25 EP disclosed
CN-117425732-A Biocatalysts and methods for synthesizing pregabalin intermediates 宁波酶赛生物工程有限公司 2024-01-19 CN disclosed
CN-116515800-A Application of PaDP protein and mutant thereof in enzymatic synthesis of pregabalin chiral intermediate 中国科学院微生物研究所 2023-08-01 CN disclosed
WO-2023088077-A1 BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF PREGABALIN INTERMEDIATES ENZYMASTER (NINGBO) BIO-ENGINEERING CO., LTD. (CN) 2023-05-25 WO disclosed
CN-114164198-A (R) - (-) -3- (carbamoylmethyl) -5-methylhexanoic acid synthetic protein, mutant and application thereof 中国科学院微生物研究所 2022-03-11 CN disclosed
CN-110903228-A Preparation method of 4-isobutyl pyrrolidone by solvent-free method 南通常佑药业科技有限公司 2020-03-24 CN disclosed
EP-3275860-B1 METHOD FOR PREPARING PREGABALIN INTERMEDIATE 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID WITHOUT SOLVENT ZHEJIANG HUAHAI PHARM CO LTD (CN) 2020-02-26 EP disclosed
CN-107428761-B The method for preparing dipeptidyl peptidase-4 (DPP-4) inhibitor 李氏制药有限公司 2019-11-05 CN disclosed
US-10450315-B2 Process for the preparation of dipeptidyl peptidase-4 (DPP-4) enzyme inhibitor LEE PHARMA LIMITED (IN) 2019-10-22 US disclosed
US-10450315-B2 Process for the preparation of dipeptidyl peptidase-4 (DPP-4) enzyme inhibitor LEE PHARMA LIMITED (IN) 2019-10-22 US disclosed
EP-2916832-B1 A PROCESS FOR THE PREPARATION OF PREGABALIN HIKAL LTD (IN) 2019-01-16 EP disclosed
US-10131625-B2 Method for preparing 3-carbamoymethyl-5-methylhexanoic acid in recycling way ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2018-11-20 US disclosed
US-20180265513-A1 NOVEL PROCESS FOR THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR LEE PHARMA LIMITED (IN) 2018-09-20 US disclosed
EP-3275860-A1 METHOD FOR PREPARING PREGABALIN INTERMEDIATE, 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID, USING SOLVENT-FREE REACTION Zhejiang Huahai Pharmaceutical Co., Ltd (CN) 2018-01-31 EP disclosed
US-20170369422-A1 METHOD FOR PREPARING PREGABALIN INTERMEDIATE 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID WITHOUT SOLVENT ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2017-12-28 US disclosed
CN-107428761-A Prepare dipeptidyl peptidase 4(DPP‑4)The method of inhibitor 李氏制药有限公司 2017-12-01 CN disclosed
US-20170334836-A1 METHOD FOR PREPARING 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID IN RECYCLING WAY ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2017-11-23 US disclosed
US-20170334836-A1 METHOD FOR PREPARING 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID IN RECYCLING WAY ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2017-11-23 US disclosed
EP-3242879-A1 NOVEL PROCESS FOR THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR Lee Pharma Ltd. (IN) 2017-11-15 EP disclosed
EP-3210967-A1 METHOD FOR PREPARING 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID IN RECYCLING WAY Zhejiang Huahai Pharmaceutical Co., Ltd (CN) 2017-08-30 EP disclosed
WO-2016110750-A1 NOVEL PROCESS FOR THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR LEE PHARMA LIMITED (IN) 2016-07-14 WO disclosed
WO-2016110750-A1 NOVEL PROCESS FOR THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR LEE PHARMA LIMITED (IN) 2016-07-14 WO disclosed
US-9346755-B2 Kinetic resolution THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN TRINITY COLLEGE, UNIVERSITY OF DUBLIN (IE) 2016-05-24 US disclosed
CN-105481712-A Racemization recycling method of Pregabalin intermediate mother liquor from resolution CHANGZHOU SUNLIGHT PHARM CO LTD 2016-04-13 CN disclosed
EP-2391600-B1 INTERMEDIATES IN THE ENANTIOSELECTIVE SYNTHESIS OF 3-(AMINOMETHYL)-5-METHYL-HEXANOIC ACID PROVOST FELLOWS & SCHOLARS COLLEGE OF THE HOLY UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2016-01-06 EP disclosed
EP-2391600-B1 INTERMEDIATES IN THE ENANTIOSELECTIVE SYNTHESIS OF 3-(AMINOMETHYL)-5-METHYL-HEXANOIC ACID PROVOST FELLOWS & SCHOLARS COLLEGE OF THE HOLY UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2016-01-06 EP disclosed
EP-2035368-B1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES LABORATORIO CHIMICO INT SPA (IT) 2015-05-27 EP disclosed
US-20150073170-A1 KINETIC RESOLUTION The Provost, Fellows, Foundation Scholars, and the Other Members of the Board, of the College of the (IE) 2015-03-12 US disclosed
CN-102465157-B Preparation of pregabalin chiral intermediate with bio-enzyme method ZHEJIANG JIUZHOU PHARM CO LTD 2014-11-26 CN disclosed
CN-102465157-B Preparation of pregabalin chiral intermediate with bio-enzyme method ZHEJIANG JIUZHOU PHARM CO LTD 2014-11-26 CN disclosed
US-20140323758-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE LUPIN LIMITED (IN) 2014-10-30 US disclosed
US-20140323758-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE LUPIN LIMITED (IN) 2014-10-30 US disclosed
EP-2782901-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE Lupin Limited (IN) 2014-10-01 EP disclosed
EP-2782901-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE Lupin Limited (IN) 2014-10-01 EP disclosed
US-8563775-B2 Process for the preparation of (R)-(−)-3-(carbamoylmethyl)-5-methylhexanoic acid and of pregabalin and synthesis intermediates LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 2013-10-22 US disclosed
US-8546112-B2 Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester SANDOZ AG (CH) 2013-10-01 US disclosed
US-8546112-B2 Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester SANDOZ AG (CH) 2013-10-01 US disclosed
US-8476441-B2 Intermediates in the enantioselective synthesis of 3-(aminomethyl)-5-methyl-hexanoic acid THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2013-07-02 US disclosed
US-8476441-B2 Intermediates in the enantioselective synthesis of 3-(aminomethyl)-5-methyl-hexanoic acid THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2013-07-02 US disclosed
WO-2013076630-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE LUPIN LIMITED (IN) 2013-05-30 WO disclosed
WO-2013076630-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE LUPIN LIMITED (IN) 2013-05-30 WO disclosed
CN-101500985-B Process for the preparation of (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid and of pregabalin and synthesis intermediates LABORATORIO CHIMICO INT SPA 2013-04-03 CN disclosed
EP-2294207-B1 Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester SANDOZ AG (CH) 2012-09-26 EP disclosed
WO-2012093411-A2 PROCESS FOR THE PREPARATION OF R-(-)-3- (CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND THE INTERMEDIATES DR BRAJA SUNDAR PRADHAN (IN) 2012-07-12 WO disclosed
CN-102465157-A Preparation of pregabalin chiral intermediate by biological enzyme method ZHEJIANG JIUZHOU PHARM CO LTD 2012-05-23 CN disclosed
CN-102465157-A Preparation of pregabalin chiral intermediate by biological enzyme method ZHEJIANG JIUZHOU PHARM CO LTD 2012-05-23 CN disclosed
US-20120046468-A1 INTERMEDIATES IN THE ENANTIOSELECTIVE SYNTHESIS OF 3-(AMINOMETHYL)-5-METHYL-HEXANOIC ACID THE PROVOST,FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY LAND AND UNDIVIDED TRINITY OF QUEEN ELIZ (IE) 2012-02-23 US disclosed
US-20120046468-A1 INTERMEDIATES IN THE ENANTIOSELECTIVE SYNTHESIS OF 3-(AMINOMETHYL)-5-METHYL-HEXANOIC ACID THE PROVOST,FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY LAND AND UNDIVIDED TRINITY OF QUEEN ELIZ (IE) 2012-02-23 US disclosed
EP-2391600-A2 INTERMEDIATES IN THE ENANTIOSELECTIVE SYNTHESIS OF 3-(AMINOMETHYL)-5-METHYL-HEXANOIC ACID The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin (IE) 2011-12-07 EP disclosed
WO-2011086565-A1 METHOD FOR PREPARATION OF ENANTIOMERICALLY ENRICHED AND/OR RACEMIC GAMMA-AMINO ACIDS LUPIN LIMITED (IN) 2011-07-21 WO disclosed
CN-102126979-A Preparation method of optically pure 3-(carbamoylmethyl)-5-methyl-hexanoic acid CHENGDU ORGANIC CHEMICALS CO 2011-07-20 CN disclosed
US-20110165636-A1 PROCESS FOR THE STEREOSELECTIVE ENZYMATIC HYDROLYSIS OF 5-METHYL-3-NITROMETHYL-HEXANOIC ACID ESTER SANDOZ AG (CH) 2011-07-07 US disclosed
US-20110165636-A1 PROCESS FOR THE STEREOSELECTIVE ENZYMATIC HYDROLYSIS OF 5-METHYL-3-NITROMETHYL-HEXANOIC ACID ESTER SANDOZ AG (CH) 2011-07-07 US disclosed
WO-2011077463-A1 PROCESS FOR PREPARING PREGABALIN AND ITS INTERMEDIATE MSN LABORATORIES LIMITED (IN) 2011-06-30 WO disclosed
WO-2011077463-A1 PROCESS FOR PREPARING PREGABALIN AND ITS INTERMEDIATE MSN LABORATORIES LIMITED (IN) 2011-06-30 WO disclosed
CN-101857552-A Resolution method of 3-(carbamoylmethyl)-5-methylhexanol CHENGDU ORGANIC CHEMICALS CO 2010-10-13 CN disclosed
WO-2010086429-A2 INTERMEDIATES IN THE ENANTIOSELECTIVE SYNTHESIS OF 3-(AMINOMETHYL)-5-METHYL-HEXANOIC ACID THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2010-08-05 WO disclosed
EP-2213659-A1 Intermediates in the Enantioselective Synthesis of 3-(Aminomethyl)-5-Methyl-Hexanoic Acid The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin (IE) 2010-08-04 EP disclosed
CN-101500985-A Process for the preparation of (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid and of pregabalin and synthesis intermediates LABORATORIO CHIMICO INT SPA (IT) 2009-08-05 CN disclosed
US-20090192331-A1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 2009-07-30 US disclosed
EP-2035368-A1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES Laboratorio Chimico Internazionale S.p.A. (IT) 2009-03-18 EP disclosed
WO-2008004044-A1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES LABORATORIO CHIMICO INTERNAZIONALE S.P.A. (IT) 2008-01-10 WO disclosed
EP-0828704-B1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER LAMBERT CO (US) 2002-03-13 EP disclosed
EP-0828704-A1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER-LAMBERT COMPANY (US) 1998-03-18 EP disclosed
US-5629447-A Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-05-13 US disclosed
US-5616793-A Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid WARNER-LAMBERT COMPANY (US) 1997-04-01 US disclosed
WO-1996038405-A1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER-LAMBERT COMPANY (US) 1996-12-05 WO disclosed
WO-1996038405-A1 METHODS OF MAKING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID WARNER-LAMBERT COMPANY (US) 1996-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150073170-A1 KINETIC RESOLUTION SPR, ADH5, ADH1C CACNA2D1 4724/4885CACNB3 2975/4885CACNA1C 3442/4885
US-20090192331-A1 PROCESS FOR THE PREPARATION OF (R)-(-)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACID AND OF PREGABALIN AND SYNTHESIS INTERMEDIATES GABRA5, GRM5, GRIK5 CACNA2D1 138/4885CACNB3 130/4885CACNA1C 100/4885
US-20170369422-A1 METHOD FOR PREPARING PREGABALIN INTERMEDIATE 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID WITHOUT SOLVENT GABRG2, GRHPR, GABRG1 CACNA2D1 63/4885CACNB3 194/4885CACNA1C 49/4885
US-20180265513-A1 NOVEL PROCESS FOR THE PREPARATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME INHIBITOR DPP4, DPP7, DPP9 CACNA2D1 3416/4885CACNB3 3646/4885CACNA1C 3395/4885
US-20170334836-A1 METHOD FOR PREPARING 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID IN RECYCLING WAY ALKBH5, ALKBH3, ALKBH1 CACNA2D1 1330/4885CACNB3 2445/4885CACNA1C 1211/4885
US-20120046468-A1 INTERMEDIATES IN THE ENANTIOSELECTIVE SYNTHESIS OF 3-(AMINOMETHYL)-5-METHYL-HEXANOIC ACID FAAH, ALDH7A1, GABRE CACNA2D1 1001/4885CACNB3 1586/4885CACNA1C 1293/4885
US-10450315-B2 Process for the preparation of dipeptidyl peptidase-4 (DPP-4) enzyme inhibitor DPP4, DPP7, DPP3 CACNA2D1 3426/4885CACNB3 3789/4885CACNA1C 3352/4885
US-20140323758-A1 NOVEL PROCESS FOR RACEMIZATION OF AN OPTICALLY ACTIVE (S)-3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID TO CORRESPONDING 3-CARBAMOYLMETHYL-5-METHYL-HEXANOIC ACID RACEMATE ACMSD, HCAR3, ALKBH5 CACNA2D1 2516/4885CACNB3 894/4885CACNA1C 1411/4885
US-10131625-B2 Method for preparing 3-carbamoymethyl-5-methylhexanoic acid in recycling way ALKBH5, ALKBH1, ALKBH3 CACNA2D1 2188/4885CACNB3 3038/4885CACNA1C 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.